Company · CIK 827871
EAGLE PHARMACEUTICALS, INC.
| CIK | 827871 (SEC EDGAR) |
|---|---|
| Industry (SIC) | 2834 — Pharmaceutical Preparations |
| Incorporated in | DE |
| Business address | NJ |
| Listed | no ticker on SEC record today |
| First annual or quarterly report | 2014-05-15 |
Offerings
4 registrations| Registration | Label and status | First filed | Last event | Filings |
|---|---|---|---|---|
| 333-202592 | 2015-03-06 | 2024-12-09 | 5 | |
| 333-267827 | 2022-10-11 | 2024-11-27 | 3 | |
| 333-234742 | 2019-11-15 | 2019-12-16 | 2 | |
| 333-192984 | 2013-12-20 | 2014-02-13 | 7 |
Filings
18| Filed | Filing | Registration | Accession |
|---|---|---|---|
| 2024-12-09 | EFFECTDeclared effective | 333-202592 | 9999999995-24-003701 |
| 2024-11-27 | RWWithdrawn | 333-267827 | 0001104659-24-123691 |
| 2022-10-19 | EFFECTDeclared effective | 333-267827 | 9999999995-22-003090 |
| 2022-10-11 | S-3Shelf registered | 333-267827 | 0001104659-22-107780 |
| 2019-12-16 | EFFECTDeclared effective | 333-234742 | 9999999995-19-002823 |
| 2019-11-15 | S-3Shelf registered | 333-234742 | 0001047469-19-006334 |
| 2015-03-17 | 424B5Shelf takedown | 333-202592 | 0001047469-15-002356 |
| 2015-03-16 | 424B5Shelf takedown | 333-202592 | 0001047469-15-002294 |
| 2015-03-13 | EFFECTDeclared effective | 333-202592 | 9999999995-15-000610 |
| 2015-03-06 | S-3Shelf registered | 333-202592 | 0001104659-15-017795 |
| 2014-02-13 | 424B4Final prospectus | 333-192984 | 0001047469-14-000839 |
| 2014-02-11 | EFFECTDeclared effective | 333-192984 | 9999999995-14-000404 |
| 2014-02-04 | S-1/AAmendment | 333-192984 | 0001047469-14-000584 |
| 2014-01-28 | S-1/AAmendment | 333-192984 | 0001047469-14-000384 |
| 2014-01-22 | S-1/AAmendment | 333-192984 | 0001047469-14-000279 |
| 2014-01-09 | S-1/AAmendment | 333-192984 | 0001047469-14-000096 |
| 2013-12-20 | S-1Registration filed | 333-192984 | 0001047469-13-011312 |
| 2013-10-21 | DRSDraft made public | 377-00346 | 0000912057-13-000342 |